Thank you, Kathryn. Hello everyone and thank you for joining us today. I will review our financial results for the fourth quarter and fiscal year ended December 31st, 2023. I will then provide details on our guidance for fiscal year 2024. As a reminder, in 2023, our results benefited from a 53rd week of operations in the fourth quarter compared to the standard 52-week fiscal year in 2022 and 2024. As you have already heard on this call, the fourth quarter was strong with a record net revenue of $135.8 million. That is an increase of 23.4% compared to the prior year period. This was driven by shipment volume growth of 11.6% and higher price/mix. The volume growth was driven by an increase in both new and existing retail customers. The extra week in the fourth quarter of 2023 contributed $8.5 million to net revenue or 7.7% to growth. Excluding the extra week in the fourth quarter of 2023, net revenue increased 15.7%. Gross profit for the fourth quarter of 2023 was $45.2 million or 33.3% of net revenue compared to $33.3 million or 30.3% of net revenue for the fourth quarter of 2022. Gross profit dollars benefited mainly from higher sales. The 300 basis point gross margin expansion was driven by price increases across our entire Shellac portfolio in January 2023, a moderate promotional environment and moderating commodity and logistics costs, which were partially offset by higher packaging and labor costs. SG&A expenses for the fourth quarter of 2023 were $28.8 million or 21.2% of net revenue compared to $22.0 million or 20.0% of net revenue in the fourth quarter last year. The increase in SG&A was driven by higher marketing expense accompanied by increased employee-related costs as we added headcount to support our continued growth. Shipping and distribution expenses in the fourth quarter were $7.3 million or 5.4% of net revenue compared to $7.8 million or 7.1% of net revenue in the fourth quarter of 2022. The decrease in shipping and distribution expenses was driven by a decline in line haul rates and internal efficiencies as we continue to grow our shipment volume. Net income for the fourth quarter 2023 was $7.2 million or $0.17 per diluted share compared to $1.9 million or $0.04 per diluted share for the fourth quarter 2022. Adjusted EBITDA for the fourth quarter of 2023 was $13.9 million or 10.2% of net revenue compared to $6.9 million or 6.2% of net revenue for the fourth quarter of 2022. The extra week in the fourth quarter of 2023 contributed $900,000. Now, turning to our fiscal 2023 results. Net revenue for the year was $471.9 million. That is a 30.3% increase compared to fiscal 2022, driven by volume gains of 13.9% and higher prices and better mix across the Shellac portfolio. The volume growth was primarily driven by increases at both new and existing customers. The extra week in fiscal year 2023 contributed $8.5 million of net revenue or 2.3% to growth. Excluding the extra week, net revenue increased 28.0% in fiscal 2023. Excluding both the extra week in fiscal 2023 and the impact of avian influenza in the first quarter of 2023, net revenue increased 25.9% in fiscal 2023. Gross profit for the year was $162.3 million or 34.4% of net revenue compared to $109.4 million or 30.2% of net revenue in fiscal 2022. The change in gross profit was primarily driven by higher sales. Our gross margin benefited from increased pricing across the company's portfolio, partially offset by headwinds that included higher input costs, including commodity impacts across the Shellac business, as well as higher packaging costs. SG&A expenses for the year were $101.7 million or 21.6% of net revenue compared to $77.2 million or 21.3% of net revenue in fiscal 2022. The increase in full year SG&A was driven by increased marketing spending to support the initiatives Kathryn talked about a minute ago. Excluding marketing spend, SG&A as a percent of net sales declined by more than a point, demonstrating the scale leverage we are achieving. Shipping and distribution expenses for the year were $27.3 million or 5.8% of net revenue compared to $30.1 million or 8.3% of net revenue in fiscal year 2022. The decrease in costs was driven by favorable freight rates and internal operating efficiencies, partially offset by higher sales volumes. Net income for the year was $25.6 million or $0.59 per diluted share compared to $1.2 million or $0.03 per diluted share in fiscal year 2022. Adjusted EBITDA for the year was $48.3 million or 10.2% of net revenue compared to $16.2 million or 4.5% of net revenue in fiscal 2022. The growth in adjusted EBITDA and meaningful improvement in our adjusted EBITDA margin reflects the growing scale of our business, and we believe puts us on the right path to deliver our long-term targets. This marks the first full fiscal year since our IPO with double-digit adjusted EBITDA margin, demonstrating the benefits of our growing scale, and this is an achievement we're very proud of. The extra week in fiscal year 2023 contributed $0.9 million to adjusted EBITDA. A quick update on our capital structure. As of December 31st, 2023, we had total cash, cash equivalents, and marketable securities of $116.8 million. We had no debt outstanding. In the fiscal 2023, we generated $39 million of free cash flow. And lastly, I will note that our capital expenditures for the year came in at $11.5 million, which is near the bottom of our previously guided range and well below our initial guidance for the year. In the fourth quarter, we delayed CapEx spend for our new egg processing facility that was previously expected in Q4. This spend has been shifted to 2024. Compared to our initial CapEx guidance for the year, we also adjusted the timing of the previously mentioned digital transformation to ensure that we are fully set up for success. Now, looking ahead, for the full fiscal year 2024, we are guiding to net revenue of at least $552 million or at least 17% growth and adjusted EBITDA of at least $57 million or at least 18% growth. A couple of callouts on our net revenue cadence. It is worth noting that in the first quarter of 2023, we had a volume benefit from avian influenza, lapping this benefit in the first quarter of 2024 will be a headwind of 11 points of net revenue growth and 8 points of volume growth. On the other hand, in the second quarter of 2023, demand was lower as order patents from retailers were out of sync, which we expect will be a tailwind of 3 points for net revenue growth in the second quarter of 2024. In addition, due to an industry-wide shortage of eggs in the first half of 2023, we reduced our trade spending, which we now need to lap, creating another point of net revenue growth headwind in the first half of 2024. Additionally, in the fourth quarter of 2024, we will face a headwind from the extra week in 2023 as we are operating a standard 52-week calendar this year. Note that in 2024, we expect a normalized promotional cadence. Let me add one more housekeeping item to the revenue guidance. We regularly review our product portfolio and in the process decided to discontinue four SKUs of ghee and tub butter at the end of 2023 in order to concentrate our focus on stick butter. Combined, these SKUs generated $2.6 million in net sales for us in 2023. We anticipate that increased stick butter sales in 2024 will more than offset the rationalization and we expect growth in our butter category compared to 2023. Next, let me touch on our adjusted EBITDA guidance. Within our adjusted EBITDA guidance, we expect marketing spend to be up a few million dollars compared to 2023 as we are increasing spend on awareness focused media and tactics. We expect more of the marketing spend to occur in the second half of the year and higher adjusted EBITDA margin in the first half of the year. Additionally, the cost to produce eggs remains higher than it was just a few years ago and our operating plan assumes this will remain the case in the near-term. We don't expect any contribution to net sales growth and price/mix improvements. We increased prices for organic shell eggs while low double-digits at the beginning of January 2024, while keeping the price of conventional eggs constant and supporting them with the previously mentioned higher trade spend. We anticipate benefits from lower feed costs, mostly offset by higher butter costs, packaging costs, trade spend, labor cost, and shipping rates. Lastly on guidance, we expect fiscal year 2024 capital expenditures in the range of $35 million to $45 million. Note that this includes $11 million of timing shipped from the CapEx spend that was initially planned in 2023. We continue to evaluate our capital allocation priorities and if necessary, we'll provide updates on future earnings calls. Overall, 2023 was a strong year for Vital Farms as we navigated some challenging industry dynamics and still delivered a record year for the business with healthy growth and profitability. We are excited to carry this momentum into 2024, built on our double-digit EBITDA margin, and we are focused on increasing retail penetration to raise brand awareness and deliver our eggs to more and more households. Thank you for your time and interest in Vital Farms. We appreciate the confidence that you place in us with your investment. And with that, we will gladly take your questions.